DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Mar 2022

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2022
Quarter 1 Qtr
Quarterly report for the financial period ended 31 Mar 2022
The figures have not been audited

Attachments

Duopharma Biotech - Financial Results Q1 2022.pdf
338.8 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2022

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2022
31 Mar 2021
31 Mar 2022
31 Mar 2021
$$'000
$$'000
$$'000
$$'000
1 Revenue
185,941
166,454
185,941
166,454
2 Profit/(loss) before tax
26,646
23,176
26,646
23,176
3 Profit/(loss) for the period
20,291
17,614
20,291
17,614
4 Profit/(loss) attributable to ordinary equity holders of the parent
20,291
17,614
20,291
17,614
5 Basic earnings/(loss) per share (Subunit)
2.19
1.90
2.19
1.90
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.6700
0.6600

Remarks : 
Pursuant to MFRS 133, Earnings Per Share, the Earnings Per Share for the corresponding quarter and year to date
ended 31 March 2021 had been retrospectively adjusted to reflect the effect of the bonus shares allotted on 7 September 2021.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence



Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 17 May 2022
Category Financial Results
Reference Number FRA-23042022-00001


View original report